Flexeril and Microzide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Microzide (hydrochlorothiazide). Common drug interactions include depression among females and cataract among males.
The phase IV clinical study analyzes what interactions people have when they take Flexeril and Microzide. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.
What is Flexeril?
Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.
What is Microzide?
Microzide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 994 Microzide users. Check the latest studies of Microzide.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
41 people who take Flexeril and Microzide together, and have interactions are studied.

What are the common drug interactions of Flexeril and Microzide, by gender? *:
female:
- Depression
- Diabetes mellitus inadequate control
- Diarrhoea
- Drug effect decreased
- Drug intolerance (drug sensitivity)
- Ejection fraction decreased (systolic heart failure)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Feeling jittery
- Gangrene (body tissue dies)
- Haemangioma of spleen (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in spleen)
male:
- Cataract (clouding of the lens inside the eye)
- Fatigue (feeling of tiredness)
- Mobility decreased (ability to move is reduced)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Osteonecrosis (death of bone)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Pain
- Pain in extremity
- Rib fracture
- Tendon rupture (tear of tendon)
What are the common drug interactions of Flexeril and Microzide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Drug ineffective
40-49:
- Coronary artery stenosis (narrowing of coronary artery)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Dysphoria (generalized dissatisfaction with life)
- Facet joint syndrome (problem with movement of the facet joints of the spine)
- Facial bones fracture (bone fracture of face)
- Fall
- Hyperaesthesia
- Intervertebral disc degeneration (spinal disc degeneration)
- Osteoporosis (bones weak and more likely to break)
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
50-59:
- Pain
- Arthropathy
- Bone density decreased
- Bone loss
- Dizziness
- Emotional distress
- Foot fracture
- Mobility decreased (ability to move is reduced)
- Nausea (feeling of having an urge to vomit)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
60+:
- Anxiety
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Hip fracture
- Interstitial granulomatous dermatitis (inflammation of the skin)
- Pain
- Pneumonia bacterial (pneumonia associated with bacterial infection)
- Pneumonia viral
- Abdominal discomfort
- Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
- Back disorder
What are the existing conditions these people have? *
- Fibromyalgia (a long-term condition which causes pain all over the body): 10 people, 24.39%
- Back Pain: 9 people, 21.95%
- Stress And Anxiety: 8 people, 19.51%
- Pain: 7 people, 17.07%
- Joint Pain: 7 people, 17.07%
- Nausea (feeling of having an urge to vomit): 6 people, 14.63%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 12.20%
- Itching: 5 people, 12.20%
- Neuralgia (pain in one or more nerves): 4 people, 9.76%
- Nausea And Vomiting: 4 people, 9.76%
* Approximation only. Some reports may have incomplete information.
Do you take Flexeril and Microzide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Flexeril and Microzide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Flexeril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Microzide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Flexeril and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Microzide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and hydrochlorothiazide (the active ingredients of Flexeril and Microzide, respectively), and Flexeril and Microzide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Compazine cause Joint Swelling? - now
- Peritoneal Haemorrhage and drugs of ingredients of fentanyl citrate - now
- Could Mercaptopurine cause Pleocytosis? - 3 seconds ago
- Allegra and Prilosec drug interactions for men aged 20-29 - 3 seconds ago
- Gait Abnormal and drugs of ingredients of atorvastatin calcium - 5 seconds ago
- Drug interactions of Apriso and Amoxicillin - 7 seconds ago
- Lovaza and Lidocaine drug interactions for women aged 40-49 - 8 seconds ago
- Drug interactions of Sunosi and Profen - 10 seconds ago
- Bundle Branch Block Right and drugs of ingredients of lenalidomide - 15 seconds ago
- Dizziness in Lamisil, how severe and when it was recovered? - 20 seconds ago